Apyx Medical (FRA:BOV) Debt-to-Equity : 2.62 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Apyx Medical Debt-to-Equity?

Apyx Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.31 Mil. Apyx Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €35.64 Mil. Apyx Medical's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €13.70 Mil. Apyx Medical's debt to equity for the quarter that ended in Jun. 2024 was 2.62.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Apyx Medical's Debt-to-Equity or its related term are showing as below:

FRA:BOV' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.12 Max: 2.62
Current: 2.62

During the past 13 years, the highest Debt-to-Equity Ratio of Apyx Medical was 2.62. The lowest was 0.00. And the median was 0.12.

FRA:BOV's Debt-to-Equity is ranked worse than
96.73% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs FRA:BOV: 2.62

Apyx Medical Debt-to-Equity Historical Data

The historical data trend for Apyx Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Debt-to-Equity Chart

Apyx Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.01

0.02

1.44

Apyx Medical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															0.39	0.43	1.44	1.91	2.62

Competitive Comparison of Apyx Medical's Debt-to-Equity

For the Medical Devices subindustry, Apyx Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apyx Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Apyx Medical's Debt-to-Equity falls into.

Apyx Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Apyx Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.337	+	34.969)	/	24.485
	=	1.44

Apyx Medical's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.309	+	35.644)	/	13.7
	=	2.62

Apyx Medical (FRA:BOV) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Apyx Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Apyx Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (FRA:BOV) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

APYX:USA

Address

5115 Ulmerton Road, Clearwater, FL, USA, 33760

Website

https://apyxmedical.com

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Apyx Medical Headlines

No Headlines